<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font16">al., </span>
   <span class="font13">with </span>
   <span class="font13">for </span>
   <span class="font12">against </span>
   <span class="font12">The </span>
   <span class="font12">effects </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">quercetin </span>
   <span class="font11">flavonols </span>
   <span class="font11">binding </span>
   <span class="font11">that </span>
   <span class="font11">antiviral </span>
   <span class="font11">COVID- </span>
   <span class="font11">from </span>
   <span class="font11">potential </span>
   <span class="font11">{background </span>
   <span class="font11">had </span>
   <span class="font11">protease </span>
   <span class="font11">its </span>
   <span class="font11">this </span>
   <span class="font11">toxicity </span>
   <span class="font11">viral </span>
   <span class="font11">human </span>
   <span class="font11">This </span>
   <span class="font11">coronavirus </span>
   <span class="font11">virus </span>
   <span class="font11">were </span>
   <span class="font10">protein </span>
   <span class="font10">which </span>
   <span class="font10">activities </span>
   <span class="font10">margin </span>
   <span class="font10">ACE </span>
   <span class="font10">docking </span>
   <span class="font10">flavonoids </span>
   <span class="font10">including </span>
   <span class="font10">many </span>
   <span class="font10">molecules </span>
   <span class="font10">their </span>
   <span class="font10">{border-style </span>
   <span class="font10">infection </span>
   <span class="font10">kaempferol </span>
   <span class="font10">position </span>
   <span class="font10">Indeed, </span>
   <span class="font10">compared </span>
   <span class="font10">could </span>
   <span class="font10">drugs </span>
   <span class="font10">protective </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">between </span>
   <span class="font10">main </span>
   <span class="font10">molecule </span>
   <span class="font10">study </span>
   <span class="font10">compounds </span>
   <span class="font10">induced </span>
   <span class="font10">receptor </span>
   <span class="font10">vivo </span>
   <span class="font10">was </span>
   <span class="font10">RNA </span>
   <span class="font10">are </span>
   <span class="font10">derivatives </span>
   <span class="font10">effect </span>
   <span class="font10">enzyme </span>
   <span class="font10">group </span>
   <span class="font10">high </span>
   <span class="font10">injury </span>
   <span class="font10">reported </span>
   <span class="font10">response </span>
   <span class="font10">therapeutic </span>
   <span class="font10">these </span>
   <span class="font10">treatment </span>
   <span class="font10">ability </span>
   <span class="font10">activity </span>
   <span class="font10">acute </span>
   <span class="font10">host </span>
   <span class="font10">hydrogen </span>
   <span class="font10">inhibition </span>
   <span class="font10">oxidative </span>
   <span class="font10">rutin </span>
   <span class="font10">spike </span>
   <span class="font10">Also, </span>
   <span class="font10">al. </span>
   <span class="font10">bonds </span>
   <span class="font10">hydroxyl </span>
   <span class="font10">inhibitors </span>
   <span class="font10">isorhamnetin </span>
   <span class="font10">molecular </span>
   <span class="font10">other </span>
   <span class="font10">proteins </span>
   <span class="font10">respiratory </span>
   <span class="font10">studies </span>
   <span class="font10">According </span>
   <span class="font10">However, </span>
   <span class="font10">active </span>
   <span class="font10">affinity </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">due </span>
   <span class="font10">flavonol </span>
   <span class="font10">inflammatory </span>
   <span class="font10">myricetin </span>
   <span class="font10">natural </span>
   <span class="font10">several </span>
   <span class="font10">strong </span>
   <span class="font10">(), </span>
   <span class="font10">./s--- </span>
   <span class="font10">Med. </span>
   <span class="font10">able </span>
   <span class="font10">constitute </span>
   <span class="font10">data </span>
   <span class="font10">presence </span>
   <span class="font10">replication </span>
   <span class="font10">tested </span>
   <span class="font10">than </span>
   <span class="font10">PLpro </span>
   <span class="font10">also </span>
   <span class="font10">disease </span>
   <span class="font10">role </span>
   <span class="font10">severe </span>
   <span class="font10">silico </span>
   <span class="font10">targeting </span>
   <span class="font10">type </span>
   <span class="font10">./.. </span>
   <span class="font10">cells </span>
   <span class="font10">interactions </span>
   <span class="font10">potent </span>
   <span class="font10">showed </span>
   <span class="font10">CLpro </span>
   <span class="font10">COVID-: </span>
   <span class="font10">RdRp </span>
   <span class="font10">addition, </span>
   <span class="font10">bioavailability </span>
   <span class="font10">biological </span>
   <span class="font10">chronic </span>
   <span class="font10">effective </span>
   <span class="font10">immune </span>
   <span class="font10">interact </span>
   <span class="font10">liver </span>
   <span class="font10">medicinal </span>
   <span class="font10">most </span>
   <span class="font10">protects </span>
   <span class="font10">px; </span>
   <span class="font10">quercetin, </span>
   <span class="font10">reduce </span>
   <span class="font10">viruses </span>
   <span class="font10">vitro </span>
   <span class="font10">{font-family </span>
   <span class="font10">Biol. </span>
   <span class="font10">C-â€² </span>
   <span class="font10">Chem. </span>
   <span class="font10">Flavonols </span>
   <span class="font10">Mpro </span>
   <span class="font10">Quercetin </span>
   <span class="font10">all </span>
   <span class="font10">cell </span>
   <span class="font10">cleavage </span>
   <span class="font10">comparison </span>
   <span class="font10">dietary </span>
   <span class="font10">font-size </span>
   <span class="font10">his </span>
   <span class="font10">indicated </span>
   <span class="font10">kaempferol, </span>
   <span class="font10">may </span>
   <span class="font10">moiety </span>
   <span class="font10">morin </span>
   <span class="font10">myocardial </span>
   <span class="font10">order </span>
   <span class="font10">patients </span>
   <span class="font10">possess </span>
   <span class="font10">properties </span>
   <span class="font10">reduces </span>
   <span class="font10">related </span>
   <span class="font10">ring </span>
   <span class="font10">selected </span>
   <span class="font10">site </span>
   <span class="font10">sulfate </span>
   <span class="font10">syndrome </span>
   <span class="font10">therapy </span>
   <span class="font10">(Fig. </span>
   <span class="font10">(Mpro) </span>
   <span class="font10">Biomol. </span>
   <span class="font10">Many </span>
   <span class="font10">Med.https://doi: </span>
   <span class="font10">NLRP </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">Struct. </span>
   <span class="font10">activation </span>
   <span class="font10">antioxidant </span>
   <span class="font10">both </span>
   <span class="font10">clinical </span>
   <span class="font10">considered </span>
   <span class="font10">double; </span>
   <span class="font10">drug </span>
   <span class="font10">entry </span>
   <span class="font10">fisetin </span>
   <span class="font10">formation </span>
   <span class="font10">glycosides </span>
   <span class="font10">groups </span>
   <span class="font10">important </span>
   <span class="font10">increase </span>
   <span class="font10">inhibits </span>
   <span class="font10">leading </span>
   <span class="font10">namely </span>
   <span class="font10">nsp </span>
   <span class="font10">pathway </span>
   <span class="font10">polymerase </span>
   <span class="font10">possible </span>
   <span class="font10">prevention </span>
   <span class="font10">promising </span>
   <span class="font10">rats </span>
   <span class="font10">results </span>
   <span class="font10">revealed </span>
   <span class="font10">review </span>
   <span class="font10">significant </span>
   <span class="font10">stability </span>
   <span class="font10">substituted </span>
   <span class="font10">substitution </span>
   <span class="font10">symptoms </span>
   <span class="font10">target </span>
   <span class="font10">unit </span>
   <span class="font10">units </span>
   <span class="font10">use </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">(Wang </span>
   <span class="font10">CLpro. </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Health </span>
   <span class="font10">NF-ÎºB </span>
   <span class="font10">Pharmacol.https://doi: </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">Res. </span>
   <span class="font10">Res.https://doi: </span>
   <span class="font10">Sci.https://doi: </span>
   <span class="font10">These </span>
   <span class="font10">absence </span>
   <span class="font10">affinities </span>
   <span class="font10">aglycone </span>
   <span class="font10">animal </span>
   <span class="font10">associated </span>
   <span class="font10">based </span>
   <span class="font10">better </span>
   <span class="font10">bind </span>
   <span class="font10">blood </span>
   <span class="font10">bond </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">collaborators </span>
   <span class="font10">disturb </span>
   <span class="font10">electrostatic </span>
   <span class="font10">enzymes </span>
   <span class="font10">fact, </span>
   <span class="font10">flavonoid </span>
   <span class="font10">good </span>
   <span class="font10">has </span>
   <span class="font10">hepatotoxicity </span>
   <span class="font10">inflammasome </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibit </span>
   <span class="font10">interesting </span>
   <span class="font10">intestinal </span>
   <span class="font10">known </span>
   <span class="font10">lack </span>
   <span class="font10">lung </span>
   <span class="font10">models </span>
   <span class="font10">more </span>
   <span class="font10">novel </span>
   <span class="font10">pharmacological </span>
   <span class="font10">phytochemicals </span>
   <span class="font10">production </span>
   <span class="font10">reproductive </span>
   <span class="font10">screening </span>
   <span class="font10">solid; </span>
   <span class="font10">structure </span>
   <span class="font10">subunit </span>
   <span class="font10">such </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">./s---y </span>
   <span class="font10">Chem.https://doi: </span>
   <span class="font10">Dyn.https://doi: </span>
   <span class="font10">Fig. </span>
   <span class="font10">For </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">IL- </span>
   <span class="font10">Isorhamnetin </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Morin </span>
   <span class="font10">Owis </span>
   <span class="font10">Pharm. </span>
   <span class="font10">Rev. </span>
   <span class="font10">Sci. </span>
   <span class="font10">Toxicol.https://doi: </span>
   <span class="font10">Van </span>
   <span class="font10">Writing </span>
   <span class="font10">action </span>
   <span class="font10">additional </span>
   <span class="font10">affects </span>
   <span class="font10">after </span>
   <span class="font10">angiotensin-converting </span>
   <span class="font10">approach </span>
   <span class="font10">attachment </span>
   <span class="font10">bioactive </span>
   <span class="font10">bioactivity </span>
   <span class="font10">bold </span>
   <span class="font10">cardioprotective </span>
   <span class="font10">cardiotoxicity </span>
   <span class="font10">cases </span>
   <span class="font10">catalytic </span>
   <span class="font10">cells. </span>
   <span class="font10">centre </span>
   <span class="font10">class </span>
   <span class="font10">classes </span>
   <span class="font10">constitutes </span>
   <span class="font10">courier; </span>
   <span class="font10">crucial </span>
   <span class="font10">cytokines </span>
   <span class="font10">damage </span>
   <span class="font10">diabetic </span>
   <span class="font10">domain </span>
   <span class="font10">effects. </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">endocytosis </span>
   <span class="font10">especially </span>
   <span class="font10">essential </span>
   <span class="font10">exhibited </span>
   <span class="font10">experimental </span>
   <span class="font10">expression </span>
   <span class="font10">form </span>
   <span class="font10">four </span>
   <span class="font10">free </span>
   <span class="font10">glucuronic </span>
   <span class="font10">glucuronide </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">have </span>
   <span class="font10">hepatoprotective </span>
   <span class="font10">highly </span>
   <span class="font10">immunomodulatory </span>
   <span class="font10">inducing </span>
   <span class="font10">infections </span>
   <span class="font10">information </span>
   <span class="font10">interaction </span>
   <span class="font10">interferon </span>
   <span class="font10">involved </span>
   <span class="font10">isoquercitrin </span>
   <span class="font10">limitations </span>
   <span class="font10">low </span>
   <span class="font10">major </span>
   <span class="font10">male </span>
   <span class="font10">nephrotoxicity </span>
   <span class="font10">observed </span>
   <span class="font10">polyproteins </span>
   <span class="font10">possesses </span>
   <span class="font10">present </span>
   <span class="font10">prevents </span>
   <span class="font10">protein. </span>
   <span class="font10">proteolytic </span>
   <span class="font10">pt;} </span>
   <span class="font10">quercitrin </span>
   <span class="font10">reactivity </span>
   <span class="font10">research </span>
   <span class="font10">resource </span>
   <span class="font10">rutin, </span>
   <span class="font10">rutinoside </span>
   <span class="font10">safety </span>
   <span class="font10">secondary </span>
   <span class="font10">signs </span>
   <span class="font10">spectrum </span>
   <span class="font10">stress </span>
   <span class="font10">structures </span>
   <span class="font10">sugar </span>
   <span class="font10">supplementation </span>
   <span class="font10">suppresses </span>
   <span class="font10">synthesis </span>
   <span class="font10">system </span>
   <span class="font10">this, </span>
   <span class="font10">those </span>
   <span class="font10">through </span>
   <span class="font10">two </span>
   <span class="font10">using </span>
   <span class="font10">vitamin </span>
  </p>
 </body>
</html>
